ARTL (Artelo Biosciences, Inc. Common Stock) Stock Analysis - Politician Trades

Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of May 21, 2026, ARTL trades at $1.43 with a market cap of $3.19M and a P/E ratio of 0.00. ARTL moved +3.68% today. Year to date, ARTL is -63.59%; over the trailing twelve months it is -91.84%. Its 52-week range spans $1.25 to $85.80. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ARTL stock?

Rallies tracks politician and congressional stock disclosures for ARTL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

ARTL Key Metrics

Key financial metrics for ARTL
MetricValue
Price$1.43
Market Cap$3.19M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$85.80
52-Week Low$1.25
Volume9.98K
Avg Volume0
Revenue (TTM)$0
Net Income$-9.83M
Gross Margin0.00%

Latest ARTL News

Recent ARTL Insider Trades

  • Gorgas Gregory D. bought 1.20K (~$4.80K) on Aug 12, 2022.
  • Gorgas Gregory D. bought 1.20K (~$4.84K) on Aug 11, 2022.

ARTL Analyst Consensus

ARTL analyst coverage data. Average price target: $0.00.

Common questions about ARTL

Which politicians traded ARTL stock?
Rallies tracks politician and congressional stock disclosures for ARTL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ARTL?
Yes. Rallies tracks politician and congressional stock disclosures for ARTL, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ARTL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARTL. It does not provide personalized investment advice.
ARTL

ARTL